title: Mechanisms for vasopressin effects on intraocular pressure in anesthetized rats.
abstract: Continuous intracameral infusions of a balanced salt solution (0.175 microliter min-1) have been reported to raise intraocular pressure (IOP) in anesthetized rats. Palm et al. (1995) previously reported that this effect was attenuated significantly by inclusion of arginine-vasopressin (AVP, 10 ng 0.175 microliter-1) in the infusate. This study used experimental and computer simulation methods to investigate factors underlying these changes in IOP. First, constant intracameral infusions of artificial cerebrospinal fluid (aCSF) at different fixed rates (0.049-0.35 microliter min-1) were used to estimate the outflow resistance. Secondly, IOP responses were measured during an 2 hr intracameral infusion of either aCSF or AVP that was the sum of a small constant component (0.05 microliter min-1) and a larger periodic component (0.25 microliter min-1, cycling for 4 min on, then 4 min off); the mean infusion rate was 0.175 microliter min-1. As shown previously for 0.175 microliter min-1 constant infusions, the periodic aCSF infusion induced a significant rise in IOP that was attenuated by AVP administration. Complex demodulation analysis and the estimated gain parameter of a second order transfer function fit to the periodic responses indicated that outflow resistance increased significantly during the infusions in both aCSF and AVP groups, but that the indices of resistance did not differ significantly between aCSF and AVP infused eyes. This finding implies that changes in outflow resistance do not explain the difference in IOP responses to intracameral aCSF and AVP. The two responses differed significantly, though, in damping factors, such that the aCSF responses were considerably more underdamped than the AVP responses. It is hypothesized that aCSF-induced increase in IOP reflects both (1) a small component reflecting increased outflow resistance and (2) a larger non-resistive component. Since the non-resistive component is insensitive to pretreatment with acetazolamide, it is suggested that the aCSF-induced elevation in IOP reflects primarily vascular perfusion changes that are reduced by local vasoconstrictor actions of AVP. The latter mechanism likely maintains vascular perfusion of the globe when intraocular hypertension develops.
authors.affiliation: Department of Pharmacology, College of Medicine, Pennsylvania State University, Hershey 17033, USA.
authors.forename: C D
authors.initials: CD
authors.lastname: Balaban
authors.forename: D E
authors.initials: DE
authors.lastname: Palm
authors.forename: V
authors.initials: V
authors.lastname: Shikher
authors.forename: R V
authors.initials: RV
authors.lastname: Searles
authors.forename: L C
authors.initials: LC
authors.lastname: Keil
authors.forename: W B
authors.initials: WB
authors.lastname: Severs
mesh_terms: D000818:Animals; D001082:Aqueous Humor / Q000502:physiology; D001127:Arginine Vasopressin / Q000494:pharmacology*; D002555:Cerebrospinal Fluid; D007267:Injections; D007429:Intraocular Pressure / Q000187:drug effects*; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley; D013997:Time Factors
chemical_list: D001127:Arginine Vasopressin